Stewart Appelrouth, Director at AIM ImmunoTech Inc. (AIM), bought 90,910 shares at $0.33 ($30K) on 2024-03-15, disclosed to the SEC on 2024-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AIM | BUY | 2023-01-04 | $25K | — | Filing → |
| AIM | BUY | 2021-02-25 | $25K | — | Filing → |
| HEB | BUY | 2019-06-25 | $39K | — | Filing → |